Report #2842874

Received May 27, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: UT
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	—	—

Symptoms (1)

Rash

Symptom narrative

Rashes appearance two weeks after vaccine administration; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of rash in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, 2 weeks after receiving Shingrix, the patient experienced rash (Verbatim: Rashes appearance two weeks after vaccine administration). The outcome of the rash was unknown. It was unknown if the reporter considered the rash to be related to Shingrix. It was unknown if the company considered the rash to be related to Shingrix. Additional Information: GSK Receipt Date: 23-MAY-2025 The reporter got somebody and experienced rashes after two weeks after getting the Shingrix vaccine. The reporter want to know if this was related to the vaccine administration or not. The reporter did not consent to follow-up.